Previous studies showed that As4S4 was able to decrease positive rate of PML-RARα protein in APL patients [42], and As4S4 also makes redistribution of PML-RARα protein in leukemia cells from APL patients which is quite different from that of RA treatment [21]. Here, PML is linked to leukemia.